MoneyWorks4Me

Deccan Health Care - Quaterly Results

14 Feb 2025 Evaluate
The sales surged to Rs. 204.29 millions, up 33.15% for the December 2024 quarter as against Rs. 153.43 millions during the corresponding quarter previous year.The Net Profit of the company slipped to Rs. 1.56 millions from Rs. 5.51 millions, a decline of -71.69% on QoQ basis.A decline of 5.94 millions was observed in the OP in the quarter ended December 2024 from 12.36 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 204.29 153.43 33.15 524.35 437.61 19.82 597.29 450.22 32.67
Other Income 0.00 0.00 0.00 0.01 0.06 -83.33 0.14 0.16 -12.50
PBIDT 5.94 12.36 -51.94 25.72 30.97 -16.95 37.73 20.73 82.01
Interest 0.17 0.15 13.33 0.58 0.39 48.72 0.64 1.14 -43.86
PBDT 5.77 12.21 -52.74 25.14 30.58 -17.79 37.09 19.59 89.33
Depreciation 3.66 4.00 -8.50 10.93 11.09 -1.44 14.66 14.28 2.66
PBT 2.11 8.21 -74.30 14.21 19.49 -27.09 22.43 5.31 322.41
TAX 0.55 2.70 -79.63 3.60 5.54 -35.02 7.21 1.34 438.06
Deferred Tax -0.36 -0.51 -29.41 -1.06 -1.10 -3.64 -1.35 -0.85 58.82
PAT 1.56 5.51 -71.69 10.61 13.95 -23.94 15.22 3.97 283.38
Equity 226.66 203.76 11.24 226.66 203.76 11.24 203.76 170.43 19.56
PBIDTM(%) 2.91 8.06 -63.91 4.91 7.08 -30.69 6.32 4.60 37.19
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..